Disease stratification in GCA and PMR: state of the art and future perspectives

A Tomelleri, KSM van der Geest, MA Khurshid… - Nature Reviews …, 2023 - nature.com
Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are closely related conditions
characterized by systemic inflammation, a predominant IL-6 signature, an excellent …

Polymyalgia rheumatica

G Espígol-Frigolé, C Dejaco, SL Mackie, C Salvarani… - The Lancet, 2023 - thelancet.com
Polymyalgia rheumatica is an inflammatory disease producing pain and stiffness, mainly in
the shoulders and pelvic girdle, in people older than 50 years. Elevation of acute phase …

[HTML][HTML] Subclinical giant cell arteritis in polymyalgia rheumatica: Concurrent conditions or a common spectrum of inflammatory diseases?

C Salvarani, R Padoan, L Iorio, A Tomelleri… - Autoimmunity …, 2023 - Elsevier
Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are common conditions in older
adults. Their clinical connection has been recognized over time, with many patients …

Why is polymyalgia rheumatica a disease of older adults? Explanations through etiology and pathogenesis: a narrative review

I Coskun Benlidayi - Clinical Rheumatology, 2024 - Springer
Polymyalgia rheumatica is one of the most common inflammatory rheumatic conditions in
older adults. The disease is characterized by pain and stiffness in the shoulder and pelvic …

Elderly-onset rheumatoid arthritis vs. polymyalgia rheumatica: differences in pathogenesis

J Wu, F Yang, X Ma, J Lin, W Chen - Frontiers in Medicine, 2023 - frontiersin.org
Rheumatoid arthritis is a chronic autoimmune disease that mainly affects the facet joints.
Elderly-onset rheumatoid arthritis appears to exhibit symptoms similar to those of …

Aberrant phenotype of circulating antigen presenting cells in giant cell arteritis and polymyalgia rheumatica

RD Reitsema, BC Hesselink, WH Abdulahad… - Frontiers in …, 2023 - frontiersin.org
Background Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR) are overlapping
inflammatory diseases. Antigen-presenting cells (APCs), including monocytes and dendritic …

Immune checkpoint inhibitor-mediated polymyalgia rheumatica versus primary polymyalgia rheumatica: comparison of disease characteristics and treatment …

OCB Vermeulen, E Brouwer, RHJA Slart… - …, 2024 - academic.oup.com
Objectives To compare clinical characteristics, imaging findings and treatment requirements
of patients with immune checkpoint inhibitor-mediated polymyalgia rheumatica (ICI-PMR) …

Steroid-sparing agents in polymyalgia rheumatica: how will they fit into the treatment paradigm?

C Ricordi, N Pipitone, C Marvisi… - Expert Review of …, 2023 - Taylor & Francis
Introduction Polymyalgia rheumatica is a common inflammatory rheumatic disease in
subjects aged 50 years or older and classically presents with shoulder and/or pelvic girdle …

Investigational agents for polymyalgia rheumatica treatment: assessing the critical needs for future development

L Iorio, R Padoan, M Bond, C Dejaco - Expert Opinion on …, 2024 - Taylor & Francis
Introduction Polymyalgia rheumatica (PMR) is an inflammatory rheumatic disorder
characterized by pain and stiffness in the shoulder and pelvic girdles, constitutional …

Comment on: Immune checkpoint inhibitor-mediated polymyalgia rheumatica versus primary polymyalgia rheumatica: comparison of disease characteristics and …

C Manzo, M Natale, M Isetta, A Castagna - Rheumatology, 2024 - academic.oup.com
DEAR EDITOR, We read with great interest the article entitled 'Immune checkpoint inhibitor-
mediated polymyalgia rheumatica versus primary polymyalgia rheumatica: comparison of …